BusinessAdmin•Yahoo Finance RSS•17 hours ago
Hims & Hers Shares Surge 9% Amid Optimism Over Peptide Pipeline and Novo Nordisk Partnership
Hims & Hers shares rose 9% as investors show confidence in the company's peptide pipeline and its partnership with Novo Nordisk.
- • Hims & Hers experienced a 9% increase in stock price, driven by investor enthusiasm for its peptide pipeline.
- • The company is gaining attention for its collaboration with Novo Nordisk, a leader in diabetes and obesity treatments.
- • Investors are optimistic that the partnership will enhance Hims & Hers' product offerings and market position.
Source: Yahoo Finance RSS
Read original →
